Research and Innovation Circle of Hyderabad (RICH) today announced the members of the 4th cohort of its Acceleration Initiative for Devices and Diagnostics (AID) programme.
Launched in 2021, the AID programme is specifically designed to address the challenges that innovators in the life sciences ecosystem face while taking their products to market. These include limited access to equipment and prototyping facilities, difficulties in obtaining clinical samples for testing, lack of testing and validation facilities, inadequate clinical inputs during product development, uncertainties surrounding regulatory approvals, and a dearth of mentorship opportunities to provide an understanding of digital technologies, manufacturing, demand, marketing, and pricing issues.
“Through continuous efforts and strategic collaborations, we have built a comprehensive and vibrant multi-disciplinary ecosystem in partnership with academic and research institutions, as well as key hospitals in Hyderabad,” said Rashmi Pimpale, CEO of RICH, “to really expand the scope of our AID programme, and help start-ups in the life sciences space realise their full potential. We extend a warm welcome to the members of the newest cohort and look forward to witnessing their contributions in driving the advancement of the MedTech sector in Telangana and India.”